Matrix News

Xylyx Bio awarded $2.45M NIH SBIR grant from NIDDK to facilitate development of effective drugs for fibrotic liver disease

Press Releases September 16, 2024

Xylyx Bio awarded $2.45M NIH SBIR grant from NIDDK to facilitate development of effective drugs for fibrotic liver disease

Xylyx Bio awarded $2.26M NIH SBIR grant from National Cancer Institute

Press Releases June 14, 2024

Xylyx Bio awarded $2.26M NIH SBIR grant from National Cancer Institute

Lung-mimetic hydrofoam sealant to treat pulmonary air leak

Journal Papers January 27, 2024

Lung-mimetic hydrofoam sealant to treat pulmonary air leak

Xylyx Bio and Alec Batis partner to launch Sweet Chemistry, a groundbreaking line of evidence-based regenerative skincare products

Press Releases August 1, 2023

Xylyx Bio and Alec Batis partner to launch Sweet Chemistry, a groundbreaking line of evidence-based regenerative skincare products

Guide to extracellular matrices (and how to avoid common problems)

Media Coverage June 6, 2023

Guide to extracellular matrices (and how to avoid common problems)

Matrikyne peptides safe and effective in improving skin appearance

Media Coverage April 6, 2023

Matrikyne peptides safe and effective in improving skin appearance

Clinical study shows Xylyx Bio’s Matrikynes® significantly improves the structure, function, and appearance of skin

Press Releases April 5, 2023

Clinical study shows Xylyx Bio's Matrikynes® significantly improves the structure, function, and appearance of skin

Choosing extracellular matrix for cultured cells

Media Coverage September 6, 2022

Choosing extracellular matrix for cultured cells

Xylyx Bio collaboration reveals new insights into tumor drug resistance

Press Releases April 5, 2022

Xylyx Bio collaboration reveals new insights into tumor drug resistance